E Ron, MM Doody, DV Becker, AB Brill, RE Curtis, MB … - Jama, 1998 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web standards. Find out
more about why this message is appearing and what you can do to make your experience on this site
better. ... Context.— High-dose ... Cited by 173 - Related articles - BL Direct - All 4 versions
- ►snmjournals.org [PDF] RA Nordyke, FI Gilbert Jr - Journal of Nuclear Medicine, 1991 - Soc Nuclear Med Since hypothyroidism is commonplace after treatment of Graves' disease with radioiodine, the goal
should be cure of hyperthyroidism rather than avoidance of hypothyroid- ism. To find the optimal
dose to accomplish cure, we treated ... Cited by 71 - Related articles - All 5 versions
- ►endojournals.org EK Alexander, PR Larsen - Journal of Clinical Endocrinology & …, 2002 - Endocrine Soc Radioactive iodine ( 131 I) has become the most widely used therapy for patients with
hyperthyroidism caused by Graves' disease in the United States. There remains, however, significant
variability among 131 I dosing ... Cited by 71 - Related articles - BL Direct - All 4 versions
MM Kaplan, DA Meier, HJ Dworkin - … and metabolism clinics of North America, 1998 - Elsevier Radioactive iodine (RAI) therapy for hyperthyroidism was first used in 1941 by physicians at
Massachusetts General Hospital in Boston. 7 and 58 The first nuclide used was 130 I, which has a
half-life of 12.4 hours. In 1946, ... Cited by 58 - Related articles - BL Direct - All 11 versions
SA Rivkees, C Sklar, M … - Journal of …, 1998 - jcem.endojournals.org.p. … The most common cause of thyrotoxicosis in children and adults is Graves disease, an autoimmune
disorder characterized by diffuse goiter, hyperthyroidism and ophthalmopathy (1, 2, 3, 4).
Thyrotoxicosis can be also seen in ... Cited by 58 - Related articles - BL Direct - All 4 versions
- ►ecmaj.com J Ginsberg - Canadian Medical Association Journal, 2003 - ecmaj.com GRAVES' DISEASE IS CHARACTERIZED BY HYPERTHYROIDISM, diffuse goitre, ophthalmopathy and, rarely,
dermopathy. Although diagnostic testing is straightforward once Graves' disease is suspected,
physicians need to be aware of ... Cited by 55 - Related articles - BL Direct - All 16 versions
AB Watson, BEW Brownlie, CM Frampton, … - Clinical …, 1988 - interscience.wiley.com The clinical outcome of 199 patients with Graves' disease treated with standardized 185MBq 131 I
therapy doses has been analysed. Most patients were controlled with antithyroid drugs prior to the
131 I therapy, and also received ... Cited by 45 - Related articles - All 3 versions
- ►snmjournals.org [PDF] DAKC Huysmans, WCAM Buijs, MTP van de … - Journal of Nuclear …, 1996 - Soc Nuclear Med In patients with a large, multinodular goiter (>100 g), radiation absorbed doses in the thyroid,
surrounding tissues and remainder of the body were estimated after therapeutic administration
of1311(3.7 MBq or 100 /nCi/g of ... Cited by 40 - Related articles - BL Direct - All 6 versions
L Wartofsky - Thyroid, 1997 - liebertonline.com Page 1. THYROID Volume 7, Number 2, 1997 Mary Ann Liebert, Inc. Radioiodine Therapy for
Graves' Disease: Case Selection and Restrictions Recommended to Patients in North America
LEONARD WARTOFSKY ABSTRACT Each of the three major therapies for ... Cited by 40 - Related articles - BL Direct - All 2 versions
DJ Topliss, CJ Eastman - Medical Journal of Australia, 2004 - mja.com.au THYROID DYSFUNCTION is common. In the United States, hypothyroidism is present in 4.6% of the
population (clini- cal, 0.3%; and subclinical, 4.3%) and hyperthyroidism in 1.3% (clinical, 0.5%;
and subclinical, 0.7%).1 A ... Cited by 38 - Related articles - View as HTML - BL Direct - All 5 versions
